Caractéristiques cliniques et épidémiologiques de la Covid-19

Severe acute respiratory syndrome coronavirus 2, the coronavirus with respiratory tropism responsible for COVID-19, was isolated for the first time in China at the end of 2019. Several months after its discovery and despite its pandemic spread, there are still many grey areas concerning the pathophy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahieu, Rafael, Dubée, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441978/
https://www.ncbi.nlm.nih.gov/pubmed/32863555
http://dx.doi.org/10.1016/j.actpha.2020.08.006
_version_ 1783573385550233600
author Mahieu, Rafael
Dubée, Vincent
author_facet Mahieu, Rafael
Dubée, Vincent
author_sort Mahieu, Rafael
collection PubMed
description Severe acute respiratory syndrome coronavirus 2, the coronavirus with respiratory tropism responsible for COVID-19, was isolated for the first time in China at the end of 2019. Several months after its discovery and despite its pandemic spread, there are still many grey areas concerning the pathophysiology and treatment of COVID-19. However, we have strong data on its epidemiological characteristics and the clinical expression of this disease is now well described.
format Online
Article
Text
id pubmed-7441978
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-74419782020-08-24 Caractéristiques cliniques et épidémiologiques de la Covid-19 Mahieu, Rafael Dubée, Vincent Actual Pharm Article Severe acute respiratory syndrome coronavirus 2, the coronavirus with respiratory tropism responsible for COVID-19, was isolated for the first time in China at the end of 2019. Several months after its discovery and despite its pandemic spread, there are still many grey areas concerning the pathophysiology and treatment of COVID-19. However, we have strong data on its epidemiological characteristics and the clinical expression of this disease is now well described. Elsevier Masson SAS. 2020-10 2020-08-21 /pmc/articles/PMC7441978/ /pubmed/32863555 http://dx.doi.org/10.1016/j.actpha.2020.08.006 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mahieu, Rafael
Dubée, Vincent
Caractéristiques cliniques et épidémiologiques de la Covid-19
title Caractéristiques cliniques et épidémiologiques de la Covid-19
title_full Caractéristiques cliniques et épidémiologiques de la Covid-19
title_fullStr Caractéristiques cliniques et épidémiologiques de la Covid-19
title_full_unstemmed Caractéristiques cliniques et épidémiologiques de la Covid-19
title_short Caractéristiques cliniques et épidémiologiques de la Covid-19
title_sort caractéristiques cliniques et épidémiologiques de la covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441978/
https://www.ncbi.nlm.nih.gov/pubmed/32863555
http://dx.doi.org/10.1016/j.actpha.2020.08.006
work_keys_str_mv AT mahieurafael caracteristiquescliniquesetepidemiologiquesdelacovid19
AT dubeevincent caracteristiquescliniquesetepidemiologiquesdelacovid19

Ejemplares similares